Opentrons

Executive Summary

Opentrons Labworks Inc. is democratizing laboratory automation with its flexible, AI-enabled robotic platforms that automate repetitive tasks such as pipetting. Founded in 2015 and headquartered in Brooklyn, the company offers open-source hardware and software that allows scientists to focus on analysis and discovery. Its reconfigurable robots serve sectors including diagnostics, drug delivery, and digital health, making advanced automation accessible to research labs of all sizes. By lowering the cost and complexity of automation, Opentrons enables faster experimentation and scaling of workflows, positioning itself as a key player in the life sciences tools market.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation OT-3 robot with enhanced AI capabilities70% success
• Q2 2027Strategic partnership with a major pharmaceutical or diagnostics company60% success
• Q1 2027Series C or later funding round exceeding $50M65% success